Please Wait
Applying Filters...
menu
    • menu
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Menu

    Azetukalner

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Xenon Highlights 2026 Milestones At J.P. Morgan Health Conference
    Xenon Highlights 2026 Milestones At J.P. Morgan Health Conference

    12 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/12/3216905/33485/en/Xenon-Outlines-Key-Upcoming-Milestones-at-the-2026-J-P-Morgan-Healthcare-Conference.html

    GLOBENEWSWIRE
    12 Jan 2026
    Share Share
    Xenon Presents 48-Month Azetukalner OLE Data for Epilepsy at AES
    Xenon Presents 48-Month Azetukalner OLE Data for Epilepsy at AES

    05 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/05/3200741/33485/en/Xenon-Showcases-New-48-Month-Azetukalner-OLE-Study-Data-in-Epilepsy-at-AES-2025.html

    GLOBENEWSWIRE
    05 Dec 2025
    Share Share
    Xenon Announces Azetukalner Epilepsy Webinar at AES 2025
    Xenon Announces Azetukalner Epilepsy Webinar at AES 2025

    03 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/03/3198896/33485/en/Xenon-Announces-Investor-Webinar-Highlighting-Azetukalner-and-Epilepsy-Data-from-AES-2025.html

    GLOBENEWSWIRE
    03 Dec 2025
    Share Share
    Xenon To Unveil Azetukalner OLE Study Results In Epilepsy At AES
    Xenon To Unveil Azetukalner OLE Study Results In Epilepsy At AES

    25 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/25/3194314/33485/en/Xenon-to-Present-New-Azetukalner-OLE-Study-Data-in-Epilepsy-at-AES-2025.html

    GLOBENEWSWIRE
    25 Nov 2025
    Share Share
    Xenon Names Tucker Kelly as CFO
    Xenon Names Tucker Kelly as CFO

    16 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/16/3167905/33485/en/Xenon-Announces-Appointment-of-Tucker-Kelly-as-Chief-Financial-Officer.html

    GLOBENEWSWIRE
    16 Oct 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.